glp-1 egfr cut off Hemoglobin A1c Reduction With the Receptor Agonist Semaglutide Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs 2. Integration of SGLT2i in

Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial

A doctor can provide guidance on appropriate dosage, dietary support, and potential interactions with other treatments

When evaluating a patient for DGp, it is important to tease out various upper, and lower GI symptoms with a detailed medical history and to exclude other common diseases with similar manifestations

Common adverse events of GLP-1RAs include nausea, vomiting, diarrhea, and constipation, with a significantly higher incidence of nausea than that of placebo [47] [48]

With clinicians prioritizing treatment efficacy and patient outcomes, liraglutide aligns with both therapeutic objectives and safety requirements, making it the central component of comprehensive diabetes treatment strategies

2013 Sep;28(6):551-9